open access

Vol 77, No 2 (2009)
EDUKACJA. Zmniejszmy ciężar przewlekłej obturacyjnej choroby płuc (cz. II)
Published online: 2009-03-16
Submitted: 2013-02-22
Get Citation

Strategies to reduce dynamic hyperinflation in chronic obstructive pulmonary disease

Richard Casaburi
Pneumonol Alergol Pol 2009;77(2):192-195.

open access

Vol 77, No 2 (2009)
EDUKACJA. Zmniejszmy ciężar przewlekłej obturacyjnej choroby płuc (cz. II)
Published online: 2009-03-16
Submitted: 2013-02-22

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Strategies to reduce dynamic hyperinflation in chronic obstructive pulmonary disease

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 2 (2009)

Pages

192-195

Published online

2009-03-16

Bibliographic record

Pneumonol Alergol Pol 2009;77(2):192-195.

Authors

Richard Casaburi

References (17)
  1. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002; 20(4): 799–805.
  2. Katula JA, Rejeski WJ, Wickley KL, et al. Perceived difficulty, importance, and satisfaction with physical function in COPD patients. Health Qual Life Outcomes. 2004; 2: 18.
  3. O'Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004; 23(6): 832–840.
  4. O'Donnell DE, Voduc N, Fitzpatrick M, et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004; 24(1): 86–94.
  5. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160(2): 542–549.
  6. Liesker JJW, Van De Velde V, Meysman M, et al. Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD. Respir Med. 2002; 96(8): 559–566.
  7. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981; 1(8222): 681–686.
  8. O'Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med. 1997; 155(2): 530–535.
  9. Somfay A, Porszasz J, Lee SM, et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J. 2001; 18(1): 77–84.
  10. Dean NC, Brown JK, Himelman RB, et al. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis. 1992; 146(4): 941–945.
  11. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers". Lancet. 1981; 1(8226): 907–909.
  12. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol (1985). 2004; 97(5): 1637–1642.
  13. Goto S, Porszasz J, Sakurai S, et al. Effect of helium breathing on dynamic hyperinflation, minute ventilation and exercise tolerance in severe COPD patients. Am. J. Respir. Crit. Care Med. 2004; 169: A467.
  14. Lacasse Y, Guyatt GH, Goldstein RS. The components of a respiratory rehabilitation program: a systematic overview. Chest. 1997; 111(4): 1077–1088.
  15. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest. 2005; 128(4): 2025–2034.
  16. Casaburi R, Kukafka D, Cooper CB, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005; 127(3): 809–817.
  17. Emtner M, Porszasz J, Burns M, et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003; 168(9): 1034–1042.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl